SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Steve168 who wrote (17461)7/28/2003 1:23:29 PM
From: Sergio H  Read Replies (1) | Respond to of 78523
 
Steve, a while back we exchanged some thoughts on China plays. Chinese stocks continue to be red hot due to the expectation that China will revalue their currency.



To: Steve168 who wrote (17461)7/29/2003 7:57:19 PM
From: quasimodo  Read Replies (1) | Respond to of 78523
 
PCYC questions :-

Hi Steve, took a quick look at PCYC and some questions ...

1) For the 6 months ended dec 31st, 2002, r&d expense decreased to 11,703 as compared to 20,125 due to personnel reductions. Do you have any info on where these reductions were made ? Will it hurt the development pipeline in the future ?

2) Cash burn - they have been averaging cash burn @ 28,945 for the past 3 years. So this year, they should have net cash + marketable securities = 72,468 which leaves a net value (excluding all liabilities) of about $4.3 at year end.

What are your estimates of net-net value at fiscal year end ?

3) Options - 654,469 oustanding at a weighted average excercise price of $4.14. Do you see any dilution because of this ?

4) Drug trials - I am not very familiar with this process. Would you be able to explain a little more about how this works and how long before the drug is approved ?

5) Leases - The company has non-cancellable leases expiring in 2004. Do you consider this as debt ? What do you think the company can get when they renew the lease in 2004 ?

6) Competetion ?

Thanks,

Nice idea